XBI250103C85000
- 7.32
- 0.000.00%
SPDR S&P Biotech ETF Newsroom
Solid Biosciences Stock Jumps 11% Post-market on FDA Update
US stocks closed: inflation concerns caused the stock index to plummet 6% after Nvidia hit a record high
① The Nasdaq China Golden Dragon Index closed down 0.2%, with mixed gains and losses; ② Nvidia launched Project DIGITS, a personal computing product; ③ Xiaopeng Huitian: Flying Cars will be mass-produced and delivered in 2026; ④ Vaccine stocks soared, Modena rose nearly 12%, and Novavax rose nearly 11%.
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Arbutus Could Benefit From Big Pharma Bird Flu Vaccines: Jefferies
Stocks Sink As Bond Yields Soar, Nvidia Eyes Worst Day In 4 Months, Bitcoin Tumbles To $97,000: What's Driving Markets Tuesday?
Looking Into Gilead Sciences's Recent Short Interest
Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
Moderna, Novavax and Other Vaccine Names Extend Gains Amid COVID/flu Concerns
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Spotlight on Moderna: Analyzing the Surge in Options Activity
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
Bird Flu Claims First U.S. Life in Louisiana
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
AbbVie Announced Q4 2024 Earnings To Include $1.6B Acquired IPR&D Costs, Impacting EPS By $0.88; Final Results Pending; Q4 Adj EPS $2.06-$2.10; FY24 Adj EPS Guidance $10.02-$10.06
Why Moderna (MRNA) Stock Is Trading Higher
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development
Moderna CEO Letter Says With A Full Season Of RSV Contracting In 2025, Expect To Increase MRESVIA's Market Share In U.S. And Market Access Globally; Plan To Bring Manufacturing Plants Online In The UK, Canada And Australia In 2025